A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer - Related Studies

A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer

This study has been completed.

Study NCT00078260. Last updated on May 30, 2008. Information provided by Eli Lilly and Company

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Non-Small Cell Lung Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Non-Small-Cell Lung
		Lung Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		pemetrexed

5	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Eli Lilly and Company